Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Suspended × Lymphoma, B-Cell × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Unknown 12 Recruiting 7 Not yet recruiting 3 Completed 2 Withdrawn 1 Terminated 1 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ototoxicity 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, B-Cell 1 Hepatoblastoma 1 Depression 1 Colorectal Neoplasms 1 Anxiety Disorders 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04697290 2022-02-14

CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.

Beijing Tsinghua Chang Gung Hospital

Phase EARLY_PHASE1 Suspended

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡